Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 10/20 | 0.63 |
| ▸ | PRMT5 | O14744 | 2/20 | 0.63 |
| ▸ | WDR77 | Q9BQA1 | 2/20 | 0.63 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.61 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.61 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.60 |
| ▸ | DPP4 | P27487 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.60 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.60 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.60 |
| ▸ | GAPDH | P04406 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.60 |
| ▸ | STAT6 | P42226 | 1/20 | 0.60 |
| ▸ | PI4KA | P42356 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.60 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15012908 | 0.87 | PRMT5 (0.66) | AHCYPRMT5WDR77ADORA3ADORA2B | |
| SCHEMBL29913822 | 0.87 | PRMT5 (0.69) | AHCYPRMT5WDR77ADORA3ADORA2B | |
| SCHEMBL2314908 | 0.84 | ADORA3 (0.67) | PRMT5WDR77ADORA3ADORA2BADORA2A | |
| SCHEMBL5181204 | 0.84 | AHCY (0.57) | AHCYPRMT5WDR77ADORA3ADORA2B | |
| SCHEMBL16554914 | 0.82 | PRMT5 (0.65) | AHCYPRMT5WDR77ADORA3ADORA2B | |
| SCHEMBL8445904 | 0.82 | AHCY (0.69) | AHCYADORA3ADORA2BADORA2ADPP4 | |
| SCHEMBL10381791 | 0.80 | ADORA1 (0.60) | AHCYPRMT5WDR77ADORA3ADORA2B | |
| SCHEMBL313550 | 0.80 | AHCY (0.60) | AHCYADORA3ADORA2BADORA2ADPP4 | |
| 5'-Deoxyadenosine SCHEMBL14304623 | 0.79 | AHCY (0.69) | AHCYADORA3ADORA2BADORA2ADPP4 | |
| 5'-Deoxyadenosine SCHEMBL17677150 | 0.79 | AHCY (0.69) | AHCYADORA3ADORA2BADORA2ADPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024129779-A1 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | MODERNATX, INC. (US) | 2024-06-20 | — | — | WO | claimed |
| WO-2024031087-A2 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | MODERNATX, INC. (US) | 2024-02-08 | — | — | WO | claimed |
| WO-2025104494-A2 | COMPOSITIONS AND METHODS FOR MODULATING PROTEIN INTERACTIONS | VERSAMEB AG (CH) | 2025-05-22 | — | — | WO | disclosed |
| WO-2025036272-A1 | CAPPED MRNA AND METHOD OF PREPARATION THEREOF | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2025-02-20 | — | — | WO | disclosed |
| CN-119464283-A | Capped mRNA and method of making same | 苏州艾博生物科技有限公司 | 2025-02-18 | — | — | CN | disclosed |
| EP-4398884-A1 | UNIVERSAL INFLUENZA VACCINE AND METHODS OF USE | The Trustees of the University of Pennsylvania (US) | 2024-07-17 | — | — | EP | disclosed |
| EP-4387659-A2 | MRNA VACCINES AGAINST TICK SALIVARY PROTEINS, AND METHODS OF USING SAME | The Trustees of The University of Pennsylvania (US) | 2024-06-26 | — | — | EP | disclosed |
| WO-2024129779-A1 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | MODERNATX, INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| WO-2024129982-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | ORNA THERAPEUTICS, INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| WO-2024123978-A1 | IONIZABLE LIPIDS WITH MALONATE TAILS | MODERNATX, INC. (US) | 2024-06-13 | — | — | WO | disclosed |
| EP-4376814-A1 | PROCESSES FOR PREPARING LIPID NANOPARTICLE COMPOSITIONS | ModernaTX, Inc. (US) | 2024-06-05 | — | — | EP | disclosed |
| WO-2017091547-A1 | METHODS AND COMPOSITIONS FOR REPROGRAMMING CELLS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2017-06-01 | — | — | WO | disclosed |
| EP-3157573-A2 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | Moderna Therapeutics, Inc. (US) | 2017-04-26 | — | — | EP | disclosed |
| WO-2017066782-A1 | HYDROPHOBIC MRNA CAP ANALOGS | MODERNATX, INC. (US) | 2017-04-20 | — | — | WO | disclosed |
| WO-2017011773-A2 | CODON-OPTIMIZED NUCLEIC ACIDS ENCODING ANTIBODIES | MODERNATX, INC. (US) | 2017-01-19 | — | — | WO | disclosed |
| WO-2016106298-A1 | VISUALIZING MODIFIED NUCLEOTIDES AND NUCLEIC ACID INTERACTIONS IN SINGLE CELLS | SIGMA-ALDRICH CO. LLC (US) | 2016-06-30 | — | — | WO | disclosed |
| WO-2016094783-A1 | COMPOSITIONS AND METHODS FOR THE PRODUCTION OF SCAAV | VOYAGER THERAPEUTICS, INC. (US) | 2016-06-16 | — | — | WO | disclosed |
| WO-2015196128-A2 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | MODERNA THERAPEUTICS, INC. (US) | 2015-12-23 | — | — | WO | disclosed |
| EP-2694660-A1 | EFFICIENT PROTEIN EXPRESSION IN VIVO USING MODIFIED RNA (MOD-RNA) | The General Hospital Corporation (US) | 2014-02-12 | — | — | EP | disclosed |
| WO-2012138453-A1 | EFFICIENT PROTEIN EXPRESSION IN VIVO USING MODIFIED RNA (MOD-RNA) | THE GENERAL HOSPITAL CORPORATION (US) | 2012-10-11 | — | — | WO | disclosed |